Patient capital transforms the way a family business grows, makes decisions, and preserves its identity. We analyse in depth what it is, how it differs from private equity and venture capital, and why it can be the difference between transforming a company and destroying it.
In more than fifteen years of investing in Spain’s middle market, I have learned something that corporate finance textbooks do not teach: family businesses have their own rhythm. Respecting that rhythm is not weakness — it is investment intelligence.
Patient capital is, in essence, capital without an expiry date. It is money that does not have to return to a fund within five years, that does not need to generate spectacular multiples to justify itself before an investment committee, and that can afford the luxury of waiting for the right decisions to bear fruit.
But this definition, while correct, is insufficient. Patient capital is not simply money that waits. It is an investment model that fundamentally changes the way a company makes decisions, grows, transforms, and preserves its identity.
Patient capital — also called long-term capital — is investment made without a predetermined divestment horizon. In practice, this means the investor has no contractual obligation to sell their stake within a fixed period (such as the typical 5-7 years of a private equity fund) or to return capital to third parties according to an established schedule.
The concept has its roots in the investment tradition of family offices, foundations, and university endowments — institutions that manage capital with an intergenerational horizon. The idea is simple: when you remove the pressure of time, decisions change. And when decisions change, outcomes change.
Warren Buffett summarised it better than anyone: “Our favourite holding period is forever.” Berkshire Hathaway is, in essence, the greatest exercise in patient capital in modern business history. Companies that Buffett acquired in the 1970s and 1980s remain in the portfolio today — because they continue to generate value.
Understanding the differences is not an academic exercise. It is what enables a business owner to choose with full knowledge.
| Dimension | Patient capital (family office) | Private equity | Venture capital |
|---|---|---|---|
| Horizon | Indefinite (5-20+ years) | 3-7 years (fund life) | 5-10 years (fund life) |
| Source of capital | Family wealth | Institutional LPs | Institutional LPs |
| Exit obligation | None | Contractual (return capital to LPs) | Contractual |
| Target company | Profitable, mature, in transition | Profitable, with improvement levers | Pre-profit, high growth |
| Leverage | Low or none | High (LBO typical, 3-5x EBITDA) | None |
| Stake | Flexible (20-100%) | Control (51-100%) | Minority (5-30%) |
| Target IRR | 10-15% | 20-25% | 25-40% |
| Value creation | Organic + selective acquisitions | Financial + operational engineering | Scale and market capture |
Here lies the difference that explains everything. A private equity manager charges a 2% annual management fee on committed capital, regardless of performance. They also charge 20% (carry) on profits above a minimum threshold. Their incentive is to maximise returns within the fund’s lifespan.
A family office invests its own capital. It charges no fees to anyone. It wins when the company wins. It loses when the company loses. There is no intermediary, no fee structure distorting incentives. This pure alignment is what makes it possible to take decisions that would be irrational under a fund calendar.
The investment horizon is not a technical detail. It is the factor that determines most operational and strategic decisions. Here are concrete examples of how decisions change with a five-year horizon versus an indefinite one.
R&D investment. With a five-year horizon, the R&D project that will take four years to bear fruit does not get approved. With patient capital, the project is evaluated on its long-term strategic value — because there will be many more years to capture the return.
Fleet renewal. With a five-year horizon, the fleet is managed through leasing to minimise the balance-sheet impact. With patient capital, the fleet is renewed gradually through ownership — higher initial investment, but lower long-term operating costs and greater competitiveness.
Crisis management. With a five-year horizon, costs are cut aggressively to protect EBITDA. With patient capital, the analysis distinguishes between cyclical and structural downturns. If cyclical, the team is retained, training is invested in, and the moment is used to gain market share.
Compensation policy. With a five-year horizon, salaries are optimised to maximise EBITDA. With patient capital, a competitive long-term compensation policy is built, with career plans, profit-sharing, and stability. Higher short-term cost, but incomparably better retention of key talent.
One of the most relevant and least discussed aspects of patient capital is its impact on employment. According to a 2023 Harvard Business School study, companies backed by family offices show employment growth rates 12% higher and ten-year survival rates 25% higher than those backed by private equity funds in the same segment.
The reason is straightforward: patient capital does not need to “optimise” headcount to inflate EBITDA before an exit. It can afford to maintain teams during periods of lower activity, invest in training, allow learning curves, and honour the implicit commitments that many family businesses have with their employees.
At Blue Mountain, employment protection is not a presentation phrase — it is an investment criterion. We do not invest in transactions where the value creation plan is primarily based on workforce reduction.
Professionalising a family business is not a twelve-month project. It requires changing organisational culture, implementing management systems, attracting executive talent, and managing the delicate emotional transition of the founder. With patient capital, the horizon adapts to the company — not the other way around.
Patient capital allows operations to be structured with reasonable debt levels, or no debt at all. This gives the company a financial cushion that allows it to invest in growth even during difficult times and retain talent when competitors are cutting.
Family businesses typically have a very particular culture, relationships built over decades, and local reputations that are intangible assets of enormous value. Patient capital allows a more nuanced approach — understanding what works before changing anything.
When I invest my own capital in a company, my interests are perfectly aligned with those of the business owner. I have no fund pressuring me to divest, no LPs demanding a specific multiple within a specific timeframe.
Not all family businesses need the same thing. Patient capital can adapt to any scenario — from full buyouts to minority stakes, from pure equity to hybrid instruments. Each transaction is structured according to the needs of the company and the entrepreneur.
Patient capital is not the universal solution. There are situations where other types of capital are more appropriate: companies needing to scale rapidly in winner-takes-all markets, companies requiring radical and immediate restructuring, owners who want to maximise price and exit completely, sectors with narrow opportunity windows, and companies needing a specific investor profile with international networks or capital-markets expertise.
Patient capital is not the solution for every family business. It is the solution for those that need a partner who understands that building value takes time, that people matter as much as numbers, and that the best investment is one made with conviction and without haste.
At Blue Mountain, we have been applying this model for over fifteen years. More than one hundred and fifty companies, five sectors, and the same philosophy from day one: investing as if each company were our own. Because, in a sense, it is.
Founder of Blue Mountain
Over 15 years investing in Spanish companies with patient capital. Expert in business succession, corporate governance, and middle-market investment.
By Blue Mountain Capital
By Dirk Manuel Martens Jiménez
By Dirk Manuel Martens Jiménez
If you wish to explore a potential collaboration or present an investment opportunity, we invite you to contact us. We guarantee absolute confidentiality in all our conversations.